In order to do so, we generated cell lines with a doxycycline-inducible RFP plus shRNA targeting CTCF. Given the suppression of CTCF following TGFβ treatment and in mesenchymal breast cancer cell lines, we expected the knockdown to induce mesenchymal traits. Here, TGFB1 is linked to breast cancer.